Advisory Board and Editors Respiratory Medicine


Peter J. Barnes

Professor of Thoracic Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College & Honorary Consultant Physician at Royal Brompton Hospital, London. Has been the most highly cited clinical scientist in Europe & the most highly cited respiratory researcher in the world over the last 20 years. Elected a Fellow of the Royal Society in 2007. Currently a member of the Scientific Committee of the WHO/NIH global guidelines on asthma (GINA) and COPD (GOLD).

Jean Bousquet

Professor of Pulmonary Medicine at the Univeristy of Montpellier. Former Director of the INSERM Laboratory for the Immunopathology of Asthma & former chairman of the Global Initiative for Asthma (GINA). Founder & Chairman of ARIA (Allergic Rhinitis & its Impact on Asthma). Chairman of the WHO Global Alliance against Chronic Respiratory Diseases (GARD). Former President of the Societé Française d’Allergologie et d’Immunologie Clinique. Former EiC of the journal Allergy.

Wei-Chun Chin

Associate Professor, Bioengineering, University of California, Merced.

Ronald G. Crystal

Professor and Chairman, Department of Genetic Medicine, and Bruce Webster Professor of Internal Medicine, at Weill Cornell Medical College. Director of the Belfer Gene Therapy Core Facility. Attending Physician at the Weill Cornell-New York Presbyterian Hospital. Previously, Chief of Pulmonary Branch, NHLBI, NIH.

Jane C. Deng

Assistant Professor of Medicine, Division of Pulmonary and Critical Care Medicine, UCLA School of Medicine.

Delia Goletti

Delia Goletti MD, PhD, Infectious Diseases specialist. In 1992 she joined the Laboratory of Immunoregulation at the National Institutes of Health (chief Dr Fauci) working on HIV pathogenesis. In 1999 she joined the National Institute for Infectious Diseases in Rome. She has clinical duties on the tuberculosis (TB) clinic and responsibility of the Translational Research Unit where she works on TB pathogenesis, TB immunodiagnostic tests and impact of Heminths infection on HIV and TB disease.

Roy M. Harrison

Queen Elizabeth II Birmingham Centenary Professor of Environmental Health, School of Geography, Earth and Environmental Sciences. Former Director of the Institute of Public and Environmental Health, and Head of the Division of Environmental Health and Risk Management. Leader of the Birmingham node of the National Centre for Atmospheric Science. Appointed OBE in 2004.

Joachim Heinrich

Joachim Heinrich is an epidemiologist and Director of the Institute of Epidemiology I at Helmholtzzentrum München, The German Research Centre for Environmental Health. He has authored more than 500 publications and has been involved in numerous national and international epidemiological research projects examining a broad spectrum of common chronic diseases, specifically the relationship between air pollution and respiratory health.

Patrick G. Holt

Professor at the Centre for Child Health Research, University of Western Australia; Head of Division of Cell Biology, Telethon Institute for Child Health Research.

Keith Klugman

William H Foege Professor of Global Health, Emory University, Atlanta, GA and Co-Director, Respiratory and Meningeal Pathogens Research Unit, University of the Witwatersrand, Johannesburg, South Africa. Fellow of the African Academy of Microbiology; Fellow of the infectious Diseases Society of America; President of the International Society of Infectious Diseases; Recipient of John FW Herschel Medal of the Royal Society of South Africa.

Susanne Krauss-Etschmann

Main research Interests:
A) Asthma is a major cause of morbidity in the Western world but curative therapies do not exist. Hence, we aim to understand how early life environmental exposures modify lung development development and the risk of developing asthma throughout life. We use animal models of prenatal exposure to tobacco/nicotine products and human samples.
B) The importance of a steady-state balance of resident and non-resident bacterial communities for human health is increasingly appreciated. Yet, factors driving the composition of such microbial communities remain poorly understood. Therefore, we currently investigate the influence of smoke on the structure and functionality of the lung microbiome and its interaction with the lung health.
Currently Funded Projects
2012 – 2016 Chair of COST Action BM1201 “Developmental origins of Chronic Lung Disease”
2013 – 2016 Understanding the role of the lung microbiome for human health and diseases”, HMGU Environmental Health Projects, Co-PI until move to University of Kiel; Project currently continued on a collaborative basis.
Since 2013 – 2018 PI within German Center for Lung Research
2016 - 2018 Chair of “The lung Microbiota at the Interface between airway epithelium and the environment” funded by the Leibniz Association

Holger Schulz

The trained physician is Professor of Physiology at the Ludwig-Maximilians University Munich and has worked in the fields of respiratory physiology, intrapulmonary particle deposition, particulate matter associated health effects in the cardiopulmonary system. As head of the group “Lung epidemiology” he is now directing his work towards determinants of lung health and disease during growth and aging.